Floatz logo

373 assets in Non-Hodgkin Lymphoma

Therapeutic assets addressing Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
cta101
Non-Hodgkin Lymphoma
He HuangEarly P1C (36)
Metabolically Armed Cd19 Car-T Cells
Non-Hodgkin Lymphoma
The Children's Hospital of Zhejiang University School of MedicineEarly P1C (36)
Zelavespib I-124
Non-Hodgkin Lymphoma
Memorial Sloan Kettering Cancer CenterEarly P1C (36)
Bexarotene
Non-Hodgkin Lymphoma
Case Comprehensive Cancer CenterN/AD (30)
Chimeric Antigen Receptor Modified T Cells Infusion
Non-Hodgkin Lymphoma
Shanxi Bethune HospitalN/AD (30)
ds-3201b
Non-Hodgkin Lymphoma
Daiichi Sankyo Co., Ltd.P1D (30)
Kenacort
Non-Hodgkin Lymphoma
Case Comprehensive Cancer CenterN/AD (30)
Mb-Cart2019.1
Non-Hodgkin Lymphoma
Miltenyi Biomedicine GmbHN/AD (30)
Nitrogen Mustard
Non-Hodgkin Lymphoma
Case Comprehensive Cancer CenterN/AD (30)
Viosterol
Non-Hodgkin Lymphoma
Phramongkutklao College of Medicine and HospitalN/AD (30)
Ianalumab
Non-Hodgkin Lymphoma
Novartis PharmaceuticalsP1D (23)
1a46
Non-Hodgkin Lymphoma
Chimagen Biosciences, LtdP1/2NR ()
64Cu-LLP2A
Non-Hodgkin Lymphoma
Washington University School of MedicineEarly P1NR ()
ari0003
Non-Hodgkin Lymphoma
Fundacion Clinic per a la Recerca BiomédicaEarly P1NR ()
car1922t2 t cells（targeting cd19 and cd22 with car-t cells）
Non-Hodgkin Lymphoma
Tongji HospitalEarly P1NR ()
Cnct19
Non-Hodgkin Lymphoma
Juventas Cell Therapy Ltd.P2NR ()
cpo107
Non-Hodgkin Lymphoma
Conjupro Biotherapeutics, Inc.P1NR ()
gsk5926371
Non-Hodgkin Lymphoma
GlaxoSmithKlineP1/2NR ()
Ltz-301
Non-Hodgkin Lymphoma
LTZ Therapeutics, Inc.P1NR ()
Selumetinib
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P2NR ()
sp-3164
Non-Hodgkin Lymphoma
Salarius Pharmaceuticals, LLCEarly P1NR ()
Str-P004
Non-Hodgkin Lymphoma
Starna TherapeuticsEarly P1NR ()
Showing 351 to 373 of 373 assets
PreviousPage 8 of 8Next